Skip to main content

MoneyWorks4Me

Thyrocare Technologies informs about conference call

18 Mar 2020 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that a Con-call has been arranged by PhillipCapital (India) with A. Velumani, Chairman, Managing Director and CEO of the company, to discuss on Covid-19 and its impact on Indian Healthcare, at 02.30 PM today, Wednesday, March 18, 2020. The con-call arranged through Prabhudas Lilladher on the same topic has been deferred. This is subject to any last minute changes.

The above information is a part of company's filings submitted to BSE.

Peers